Lead-Seeking Approaches: 5 (Topics in Medicinal Chemistry, 5) - Hardcover
High quality leads provide the foundation for the discovery of successful clinical development candidates, and therefore the identi?cation of leads is an essential part of drug discovery. The process for the identi?cation of leads generally starts with the screening of a compound collection, either an HTS of a relatively large compound collection (hundreds of thousands to one million plus compounds) or a more focused screen of a smaller set of compounds that have been preselected for the target of interest. Virtual screening methods such as structure-based or pharmacophore-based searches can complement or replace one of the above approaches. Once hits are identi?ed from one or more of these screening methods, they need to be thoroughly characterized in order to con?rm activity and identify areas in need of optimization. Finally, once fully characterized hits are identi?ed, preliminary optimization through synthetic modi?cation is carried out to generate leads. Parallel optimization of all properties, including biological, physicochemical, and ADME is the most ef?cient approach to the identi?cation of leads. Hit characterization is described in the previous chapter. The focus of this chapter is on hit optimization and the identi?- tion of leads. After a general overview of these processes, examples taken from the literature since 2001 will be used to illustrate speci?c points. There are also a number of excellent reviews covering the lead identi?cation process [1-6].
"synopsis" may belong to another edition of this title.
From the Back Cover:
Christopher A. Lipinski: Overview of Hit to Lead: The Medicinal Chemist’s Role from HTS Retest to Lead Optimization Hand Off
Jeff W. Paslay · John E. Morin · Richard K. Harrison: High Throughput Screening in the Twenty - First Century
Jack Andrew Bikker · Lakshmi S.Narasimhan: Lead Discovery Using Virtual Screening
Maurizio Pellecchia: NMR Spectroscopy in Fragment Based Drug Design
Kevin D. Freeman-Cook · Daniel W. Kung: Hit Triage – Medicinal Chemistry Strategies to Improve the Odds of Success in Discovery
John W. Ellingboe · Adam M. Gilbert: Lead Identification
"About this title" may belong to another edition of this title.
- PublisherSpringer
- Publication date2009
- ISBN 10 3642010741
- ISBN 13 9783642010743
- BindingHardcover
- Number of pages230
- EditorHayward Matthew M.
Buy New
Learn more about this copy
£ 138.13
Shipping:
FREE
Within U.S.A.
Top Search Results from the AbeBooks Marketplace
Seller Image
Lead-Seeking Approaches (Topics in Medicinal Chemistry) [Hardcover ]
Seller:
Rating
Book Description Hardcover. Condition: new. Seller Inventory # 9783642010743
Buy New
£ 138.13
Convert currency
Stock Image
Lead-Seeking Approaches
Published by
Springer
(2009)
ISBN 10: 3642010741
ISBN 13: 9783642010743
New
Hardcover
Quantity: > 20
Seller:
Rating
Book Description Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9783642010743_lsuk
Buy New
£ 139.32
Convert currency
Stock Image
Lead-Seeking Approaches (Topics in Medicinal Chemistry, 5)
Published by
Springer
(2009)
ISBN 10: 3642010741
ISBN 13: 9783642010743
New
Hardcover
Quantity: > 20
Seller:
Rating
Book Description Condition: New. Seller Inventory # ABLIING23Mar3113020213810
Buy New
£ 147.34
Convert currency
Seller Image
Lead-Seeking Approaches
Published by
Springer Berlin Heidelberg Okt 2009
(2009)
ISBN 10: 3642010741
ISBN 13: 9783642010743
New
Hardcover
Quantity: 2
Seller:
Rating
Book Description Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -High quality leads provide the foundation for the discovery of successful clinical development candidates, and therefore the identi cation of leads is an essential part of drug discovery. The process for the identi cation of leads generally starts with the screening of a compound collection, either an HTS of a relatively large compound collection (hundreds of thousands to one million plus compounds) or a more focused screen of a smaller set of compounds that have been preselected for the target of interest. Virtual screening methods such as structure-based or pharmacophore-based searches can complement or replace one of the above approaches. Once hits are identi ed from one or more of these screening methods, they need to be thoroughly characterized in order to con rm activity and identify areas in need of optimization. Finally, once fully characterized hits are identi ed, preliminary optimization through synthetic modi cation is carried out to generate leads. Parallel optimization of all properties, including biological, physicochemical, and ADME is the most ef cient approach to the identi cation of leads. Hit characterization is described in the previous chapter. The focus of this chapter is on hit optimization and the identi - tion of leads. After a general overview of these processes, examples taken from the literature since 2001 will be used to illustrate speci c points. There are also a number of excellent reviews covering the lead identi cation process [1-6]. 232 pp. Englisch. Seller Inventory # 9783642010743
Buy New
£ 141.24
Convert currency
Seller Image
Lead-Seeking Approaches
Published by
Springer Berlin Heidelberg
(2009)
ISBN 10: 3642010741
ISBN 13: 9783642010743
New
Hardcover
Quantity: > 20
Seller:
Rating
Book Description Gebunden. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. High quality leads provide the foundation for the discovery of successful clinical development candidates, and therefore the identi?cation of leads is an essential part of drug discovery. The process for the identi?cation of leads generally starts with the . Seller Inventory # 5043275
Buy New
£ 119.83
Convert currency
Seller Image
Lead-Seeking Approaches
Published by
Springer Berlin Heidelberg
(2009)
ISBN 10: 3642010741
ISBN 13: 9783642010743
New
Hardcover
Quantity: 1
Seller:
Rating
Book Description Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - High quality leads provide the foundation for the discovery of successful clinical development candidates, and therefore the identi cation of leads is an essential part of drug discovery. The process for the identi cation of leads generally starts with the screening of a compound collection, either an HTS of a relatively large compound collection (hundreds of thousands to one million plus compounds) or a more focused screen of a smaller set of compounds that have been preselected for the target of interest. Virtual screening methods such as structure-based or pharmacophore-based searches can complement or replace one of the above approaches. Once hits are identi ed from one or more of these screening methods, they need to be thoroughly characterized in order to con rm activity and identify areas in need of optimization. Finally, once fully characterized hits are identi ed, preliminary optimization through synthetic modi cation is carried out to generate leads. Parallel optimization of all properties, including biological, physicochemical, and ADME is the most ef cient approach to the identi cation of leads. Hit characterization is described in the previous chapter. The focus of this chapter is on hit optimization and the identi - tion of leads. After a general overview of these processes, examples taken from the literature since 2001 will be used to illustrate speci c points. There are also a number of excellent reviews covering the lead identi cation process [1-6]. Seller Inventory # 9783642010743
Buy New
£ 144.36
Convert currency